Literature DB >> 2784554

Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.

M Haeger1, A Bengtson, K Karlsson, M Heideman.   

Abstract

The aim of this study was to determine whether the biologically active complement peptides C3a and C5a are formed in pregnancy and whether amniotic fluid can activate complement. C3a and C5a are formed when complement is activated. They increase smooth-muscle contraction, vascular permeability, and histamine release from mast cells and basophils. Thirty pregnant women were studied, 16 with uncomplicated and 14 with preeclamptic pregnancies. The plasma C3a and C5a concentrations before delivery were significantly higher in the preeclamptic than in the normal group. The concentrations returned to normal within 1 week. Plasma, serum, and amniotic fluid from 12 pregnant women (eight uncomplicated and four preeclamptic pregnancies) were drawn in connection with delivery. Amniotic fluid was incubated in fresh autologous serum at 37C for 15 minutes. A dose-dependent formation of C3a and C5a was registered with increasing amounts of amniotic fluid.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784554

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  13 in total

Review 1.  Complement activation in the context of stem cells and tissue repair.

Authors:  Ingrid U Schraufstatter; Sophia K Khaldoyanidi; Richard G DiScipio
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

2.  Evidence for complement activation in the amniotic fluid of women with spontaneous preterm labor and intra-amniotic infection.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Bo H Yoon; Tinnakorn Chaiworapongsa; Edi Vaisbuch; Pooja Mittal; Offer Erez; Francesca Gotsch; Moshe Mazor; Juan P Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

3.  Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes.

Authors:  Anne M Lynch; Ronald S Gibbs; James R Murphy; Patricia C Giclas; Jane E Salmon; V Michael Holers
Journal:  Obstet Gynecol       Date:  2011-01       Impact factor: 7.661

4.  Complement factor B activation in patients with preeclampsia.

Authors:  Ivan Velickovic; Mudar Dalloul; Karen A Wong; Olufunke Bakare; Franz Schweis; Maya Garala; Amit Alam; Giorgio Medranda; Jovana Lekovic; Waqas Shuaib; Andreas Tedjasukmana; Perry Little; Daniel Hanono; Ruvini Wijetilaka; Jeremy Weedon; Jun Lin; Roulhac d'Arby Toledano; Ming Zhang
Journal:  J Reprod Immunol       Date:  2015-01-03       Impact factor: 4.054

5.  Activation of the alternative pathway of complement is a feature of pre-term parturition but not of spontaneous labor at term.

Authors:  Edi Vaisbuch; Roberto Romero; Offer Erez; Shali Mazaki-Tovi; Juan Pedro Kusanovic; Eleazar Soto; Zhong Dong; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Giovanna Ogge; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  Am J Reprod Immunol       Date:  2010-02-12       Impact factor: 3.886

6.  Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Sam S Edwin; Yeon Mee Kim; Joon Seok Hong; Luis F Goncalves; Lami Yeo; Moshe Mazor; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2010-07

7.  Nanomedicines for Endothelial Disorders.

Authors:  Bomy Lee Chung; Michael J Toth; Nazila Kamaly; Yoshitaka J Sei; Jacob Becraft; Willem J M Mulder; Zahi A Fayad; Omid C Farokhzad; YongTae Kim; Robert Langer
Journal:  Nano Today       Date:  2015-12-01       Impact factor: 20.722

8.  Fragment Bb in amniotic fluid: evidence for complement activation by the alternative pathway in women with intra-amniotic infection/inflammation.

Authors:  Edi Vaisbuch; Roberto Romero; Offer Erez; Shali Mazaki-Tovi; Juan Pedro Kusanovic; Kusanovic Juan Pedro; Eleazar Soto; Francesca Gotsch; Zhong Dong; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Pooja Mittal; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-10

Review 9.  Cellular immune responses in the pathophysiology of preeclampsia.

Authors:  Derek Miller; Kenichiro Motomura; Jose Galaz; Meyer Gershater; Eun D Lee; Roberto Romero; Nardhy Gomez-Lopez
Journal:  J Leukoc Biol       Date:  2021-04-13       Impact factor: 6.011

10.  Complement Split Products in Amniotic Fluid in Pregnancies Subsequently Developing Early-Onset Preeclampsia.

Authors:  Manu Banadakoppa; Alex C Vidaeff; Uma Yallampalli; Susan M Ramin; Michael A Belfort; Chandra Yallampalli
Journal:  Dis Markers       Date:  2015-10-18       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.